DARPA calls for antibiotic replacement
November 23, 2011 by Bob Yirka in Medications
Penicillin, the first natural antibiotic discovered by Alexander Fleming in 1928
(Medical Xpress) -- Most everyone that has been keeping abreast of world events knows that the clock is ticking on antibiotics; bacteria have been slowly developing a resistance and development of new antibiotics has slowed to a crawl, thus the day will soon come that all of the tools were are currently using to fight bacterial infections will be lost, leaving everyone at their mercy. This problem has not gone unnoticed by those at the upper reaches of the military establishment in the United States, thus it should not come as a surprise to anyone that DARPA, via the Small Business Innovation Research (SBIR) program, has issued a Request for Proposals (RFP) to completely replace antibiotics with something new and better.
As noted in the RFP, the military has seen firsthand the problems with current antibiotics; soldiers experiencing wounds in war, especially those involved in fires, that develop bacterial infections now require triple the amount of hospital time to recover as doctor’s plow through a host of antibiotics in trying to find the one that will work. Clearly frightened at the prospect of sending soldiers into battle where they may encounter bioengineered bacterial agents, the top brass has decided it’s time to take another approach and to get on it now.
Instead of working to develop new antibiotics, DARPA proposes the development and use of so-called nanoparticles to deliver gene altering chemicals directly to the cells of bacteria to kill them. In addition, they are hoping that someone will be able to come up with a way to make it so that the nanoparticles and chemicals they carry can be reprogrammed on-the-fly so as to combat newly evolved or created bacteria as soon as they appear. The idea is that the nanoparticles would carry something called small interfering RNA (siRNA) which are groups of molecules that would actually do the work of shutting down the genes inside the cells of the bacteria.
DARPA has laid out the project in three phases: Study what’s out there now, develop the nanoparticle delivery system and siRNA, and devise a means for rapidly reprogramming them.
On its face, the project seems rather simple, after all, this is not science fiction, DARPA points out that just last year a research group used siRNA delivered by nanoparticles to kill the Ebola virus in four primates. Unfortunately, the problem is, it’s not as easy as it looks, all of this science is still in its infancy and if a way can be found to do what is being asked, it likely will take years, if not decades to fully develop. The success against the Ebola virus was one agent against just one virus in a structured environment. To do what DARPA wants would mean using one technique to kill any and all bad bacteria and/or viruses. Also, if it can be done, no one really knows if the procedure would be reprogrammable, much less whether it could be done on-the-fly, so it’s not really clear if anyone will be able to achieve what DARPA is asking for; though it seems for the sake of all of us, we better hope so. Turning back the clock to a time when we were helpless against the onslaught of bacterial infections would be difficult to swallow, to say the least.
© 2011 PhysOrg.com
-
E. coli bacteria more likely to develop resistance after exposure to low levels of antibiotics
Jun 14, 2011 |
not rated yet |
0
-
Tuberculosis researchers discover potential new target for treatments
Nov 21, 2011 |
not rated yet |
0
-
Outsmarting killer bacteria: Next generation of antibiotics to combat drug-resistant 'superbugs'
Sep 14, 2010 |
not rated yet |
0
-
Computer simulations aid understanding of bacterial resistance against commonly used antibiotics
Jul 21, 2011 |
not rated yet |
0
-
Researchers take early step towards devising new antibiotics
Jan 19, 2010 |
not rated yet |
0
-
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
May 25, 2012 |
not rated yet |
0
-
Limits to growth: Scientists identify key metastasis-enabling enzyme
May 22, 2012 |
5 / 5 (4) |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Potential Breakthrough in Seizure Control
10 hours ago
-
Popping/Cracked sternum.
15 hours ago
-
Which Mental Illness Encompasses This Problem?
15 hours ago
-
A question about drug tolerance
May 23, 2012
-
Poor nutrition leading to overeating?
May 23, 2012
-
Math and dyslexia?
May 21, 2012
- More from Physics Forums - Medical Sciences
More news stories
Missouri opts for untested drug for executions
(AP) -- The same anesthetic that caused the overdose death of pop star Michael Jackson is now the drug of choice for executions in Missouri, causing a stir among critics who question how the state can guarantee ...
Medications
May 24, 2012 |
not rated yet |
4
Aspirin may prevent recurrence of deep vein blood clots
(HealthDay) -- After suffering a type of blood clot called a venous thromboembolism, patients usually take a blood-thinner such as warfarin (Coumadin). But aspirin may do just as well after a period of time, ...
Medications
May 23, 2012 |
not rated yet |
2
|
Patients may receive too much acetaminophen in hospital
(HealthDay) -- Roughly 2.5 percent of admitted hospital patients may receive more than the safe daily cumulative dose of the pain-reliever acetaminophen, best known as Tylenol, on at least one day, according ...
Medications
May 23, 2012 |
1 / 5 (1) |
0
New quality standards limiting elemental impurities in medicines announced
As part of its ongoing efforts to help ensure the quality of medicines, the U.S. Pharmacopeial Convention (USP) has announced two new standards related to elemental impurities: General Chapters Elemental ImpuritiesLimits and ...
Medications
May 23, 2012 |
not rated yet |
0
Quality standards for heparin further strengthened
To help further secure a safe supply of the widelyused blood thinner heparin, a third round of revisions to quality standards for the drug has been advanced by the U.S. Pharmacopeial Convention (USP). USP's Expert Panel ...
Medications
May 23, 2012 |
not rated yet |
0
Travel to high altitudes tied to Crohn's, colitis flare-ups
(HealthDay) -- People with inflammatory bowel disease, which includes Crohn's disease and colitis, may be at increased risk for flare-ups when they fly or travel to high altitudes for skiing or mountain climbing, ...
Family history of Alzheimer's affects functional connectivity
(HealthDay) -- Cognitively normal individuals with a family history of late-onset Alzheimer's disease (AD) may display lower resting state functional connectivity in the default mode network (DMN) of the brain, ...
Transvaginal mesh op restores pelvic organ prolapse at price
(HealthDay) -- Transvaginal mesh (TVM) procedures are effective for anatomical restoration of pelvic organ prolapse (POP), but patients report a worsening of sexual function following surgery, according to ...
Tongue analysis software uses ancient Chinese medicine to warn of disease
For 5,000 years, the Chinese have used a system of medicine based on the flow and balance of positive and negative energies in the body. In this system, the appearance of the tongue is one of the measures used to classify ...
Skp2 activates cancer-promoting, glucose-processing Akt
HER2 and its epidermal growth factor receptor cousins mobilize a specialized protein to activate a major player in cancer development and sugar metabolism, scientists report in the May 25 issue of Cell.
Early physical therapist treatment associated with reduced risk of healthcare utilization and reduced overall healthcare
A new study published in Spine shows that early treatment by a physical therapist for low back pain (LBP), as compared to delayed treatment, was associated with reduced risk of subsequent healthcare utilization and lower ...
Nov 23, 2011
Rank: not rated yet
Nov 23, 2011
Rank: 2.5 / 5 (6)
But who am I kidding? We all know that this is what we should already be doing and we don't, so this new reason won't change anything.
Nov 23, 2011
Rank: 4 / 5 (1)
Nov 23, 2011
Rank: 4.2 / 5 (5)
The reason DARPA wants this isn't to protect people against things a regular immune system will help you with. It's to protect against new bio-engineered diseases created as weapons. I think the people designing such diseases will make them powerful enough that broccoli isn't going to do the trick.
Also *preach preach preach*.
Then they have to make a little Bruce Campbell out of nano-particles. Do you know how hard that would be?!
Nov 23, 2011
Rank: 4 / 5 (3)
Our homes do not need to be sterile. Our kids do not need to be protected from germs. By trying to "protect" ourselves, we only put ourselves in more danger...
Nov 23, 2011
Rank: 1 / 5 (1)
http://www.youtub...a_player
-Not covered by obamacare unfortunately.
Nov 28, 2011
Rank: not rated yet
Nov 29, 2011
Rank: not rated yet
Dec 04, 2011
Rank: not rated yet
There is another superior technology to antibiotics already...Phage Therapy. Phages can kill strains that are resistant through biofilms; Now that there is a form of gonorrhea that resist all antibiotics this technology should be combined with nano-particles and SiRna and genetic therapy... Phages can be used to ingect sirna to silence the genes that cause antibiotic resistance!, then the antibiotics can be used in smaller doses to finish the job... get to work darpa
Dec 08, 2011
Rank: not rated yet